In vitro antioxidant and antiproliferative effects of ellagic acid and its colonic metabolite, urolithins, on human bladder cancer T24 cells

Food and Chemical Toxicology

Volumn 59, Issue , 2013, Pages 428-437

  Qiu, Zhenpeng ^a   Zhou, Benhong ^b   Jin, Long ^b   Yu, Honglian ^a   Liu, Lijuan ^a   Liu, Youyi ^a   Qin, Chengchen ^a   Xie, Shuixiang ^c   Zhu, Fan ^a  

^a WUHAN UNIVERSITY   (China)

^b WUHAN UNIVERSITY   (China)

^c GANNAN MEDICAL UNIVERSITY   (China)

Author keywords

Antioxidant; Antiproliferative; Apoptosis; Ellagic acid; Urolithin

Indexed keywords

CASPASE 3; ELLAGIC ACID; HYDROGEN PEROXIDE; MALONALDEHYDE; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE P38; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHENOL DERIVATIVE; PROTEIN C JUN; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; UROLITHIN A; UROLITHIN B;

ANTIOXIDANT ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; BLADDER CANCER; CANCER CELL; CANCER INHIBITION; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

ANTIOXIDANT; ANTIPROLIFERATIVE; APOPTOSIS; ELLAGIC ACID; UROLITHIN;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTIOXIDANTS; APOPTOSIS; CASPASE 3; CELL LINE, TUMOR; CELL PROLIFERATION; COLON; COUMARINS; ELLAGIC ACID; ENTEROBACTERIACEAE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INHIBITORY CONCENTRATION 50; LIPID PEROXIDATION; MAP KINASE SIGNALING SYSTEM; METHYLATION; NEOPLASM PROTEINS; OXIDATIVE STRESS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PPAR GAMMA; REACTIVE OXYGEN SPECIES; URINARY BLADDER NEOPLASMS;

EID: 84880435708     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2013.06.025     Document Type: Article

References (51)

1. Aiken C.T., Tobin A.J., Schweitzer E.S. A cell-based screen for drugs to treat Huntington's disease. Neurobiol. Dis. 2004, 16:546-555.
2. Asur R., Balasubramaniam M., Marples B., Thomas R.A., Tucker J.D. Bystander effects induced by chemicals and ionizing radiation: evaluation of changes in gene expression of downstream MAPK targets. Mutagenesis 2010, 25:271-279.
3. Azuma H., Takahara S., Ichimaru N., Wang J.D., Itoh Y., Otsuki Y., Morimoto J., Fukui R., Hoshiga M., Ishihara T., Nonomura N., Suzuki S., Okuyama A., Katsuoka Y. Marked prevention of tumor growth and metastasis by a novel immunosuppressive agent, FTY720, in mouse breast cancer models. Cancer Res. 2002, 62:1410-1419.
4. Bialonska D., Kasimsetty S.G., Khan S.I., Ferreira D. Urolithins, intestinal microbial metabolites of Pomegranate ellagitannins, exhibit potent antioxidant activity in a cell-based assay. J. Agric. Food Chem. 2009, 57:10181-10186.
5. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72:248-254.
6. Bradham C., McClay D.R. P38 MAPK in development and cancer. Cell Cycle 2006, 5:824-828.
7. Cai Y.C., Yang G.Y., Nie Y., Wang L.D., Zhao X., Song Y.L., Seril D.N., Liao J., Xing E.P., Yang C.S. Molecular alterations of p73 in human esophageal squamous cell carcinomas: loss of heterozygosity occurs frequently; loss of imprinting and elevation of p73 expression may be related to defective p53. Carcinogenesis 2000, 21:683-689.
8. Cho S.D., Ahn N.S., Jung J.W., Yang S.R., Park J.S., Lee Y.S., Jo E.H., Hwang J.W., Lii J., Kang K.S. Critical role of the c-JunNH2-terminal kinase and p38 mitogen-activated protein kinase pathways on sodium butyrate-induced apoptosis in DU145 human prostate cancer cells. Eur. J. Cancer Prev. 2006, 15:57-63.
9. Das M., Garlick D.S., Greiner D.L., Davis R.J. The role of JNK in the development of hepatocellular carcinoma. Genes Dev. 2011, 25:634-645.
10. Finkel T. Oxidant signals and oxidative stress. Curr. Opin. Cell Biol. 2003, 15:247-254.
11. Gasmi J., Sanderson J.T. Growth inhibitory, antiandrogenic, and pro-apoptotic effects of punicic acid in LNCaP human prostate cancer cells. J. Agric. Food Chem. 2010.
12. Gusman J., Malonne H., Atassi G. A reappraisal of the potential chemopreventive and chemotherapeutic properties of resveratrol. Carcinogenesis 2001, 22:1111-1117.
13. Hayeshi R., Mutingwende I., Mavengere W., Masiyanise V., Mukanganyama S. The inhibition of human glutathione S-transferases activity by plant polyphenolic compounds ellagic acid and curcumin. Food Chem. Toxicol. 2007, 45:286-295.
14. Hong P., Li J., Li Y. Failure to detect Xenotropic murine leukaemia virus-related virus in Chinese patients with chronic fatigue syndrome. Virol. J. 2010, 7:224.
15. Huang W., Li S., Hu Y., Yu H., Luo F., Zhang Q., Zhu F. Implication of the env gene of the human endogenous retrovirus W family in the expression of BDNF and DRD3 and development of recent-onset schizophrenia. Schizophr. Bull. 2011, 37:988-1000.
16. Itoh M., Murata T., Suzuki T., Shindoh M., Nakajima K., Imai K., Yoshida K. Requirement of STAT3 activation for maximal collagenase-1 (MMP-1) induction by epidermal growth factor and malignant characteristics in T24 bladder cancer cells. Oncogene 2006, 25:1195-1204.
17. Jean-Gilles D., Li L., Ma H., Yuan T., Chichester C.O., Seeram N.P. Anti-inflammatory effects of polyphenolic-enriched red raspberry extract in an antigen-induced arthritis rat model. J. Agric. Food Chem. 2011.
18. Kasimsetty S.G., Bialonska D., Reddy M.K., Thornton C., Willett K.L., Ferreira D. Effects of pomegranate chemical constituents/intestinal microbial metabolites on CYP1B1 in 22Rv1 prostate cancer cells. J. Agric. Food Chem. 2009, 57:10636-10644.
19. Kasimsetty S.G., Bialonska D., Reddy M.K., Ma G., Khan S.I., Ferreira D. Colon cancer chemopreventive activities of pomegranate ellagitannins and urolithins. J. Agric. Food Chem. 2010, 58:2180-2187.
20. Khanduja K.L., Gandhi R.K., Pathania V., Syal N. Prevention of N-nitrosodiethylamine-induced lung tumorigenesis by ellagic acid and quercetin in mice. Food Chem. Toxicol. 1999, 37:313-318.
21. King A.E., Critchley H.O., Kelly R.W. The NF-kappaB pathway in human endometrium and first trimester decidua. Mol. Hum. Reprod. 2001, 7:175-183.
22. Kumar B., Koul S., Petersen J., Khandrika L., Hwa J.S., Meacham R.B., Wilson S., Koul H.K. P38 mitogen-activated protein kinase-driven MAPKAPK2 regulates invasion of bladder cancer by modulation of MMP-2 and MMP-9 activity. Cancer Res. 2010, 70:832-841.
23. Larrosa M., Tomas-Barberan F.A., Espin J.C. The dietary hydrolysable tannin punicalagin releases ellagic acid that induces apoptosis in human colon adenocarcinoma Caco-2 cells by using the mitochondrial pathway. J. Nutr. Biochem. 2006, 17:611-625.
24. Larrosa M., Gonzalez-Sarrias A., Yanez-Gascon M.J., Selma M.V., Azorin-Ortuno M., Toti S., Tomas-Barberan F., Dolara P., Espin J.C. Anti-inflammatory properties of a pomegranate extract and its metabolite urolithin-A in a colitis rat model and the effect of colon inflammation on phenolic metabolism. J. Nutr. Biochem. 2010, 21:717-725.
25. Liu J., Ding X., Tang J., Cao Y., Hu P., Zhou F., Shan X., Cai X., Chen Q., Ling N., Zhang B., Bi Y., Chen K., Ren H., Huang A., He T.C., Tang N. Enhancement of canonical Wnt/beta-catenin signaling activity by HCV core protein promotes cell growth of hepatocellular carcinoma cells. PLoS ONE 2011, 6:e27496.
26. Liu L., Chen X., Xie S., Zhang C., Qiu Z., Zhu F. Variant 1 of KIAA0101, overexpressed in hepatocellular carcinoma, prevents doxorubicin-induced apoptosis by inhibiting p53 activation. Hepatology 2012, 56:1760-1769.
27. Losso J.N., Bansode R.R., Trappey A.N., Bawadi H.A., Truax R. In vitro anti-proliferative activities of ellagic acid. J. Nutr. Biochem. 2004, 15:672-678.
28. Mansure J.J., Nassim R., Kassouf W. Peroxisome proliferator-activated receptor gamma in bladder cancer: a promising therapeutic target. Cancer Biol. Ther. 2009, 8:6-15.
29. Mertens-Talcott S.U., Jilma-Stohlawetz P., Rios J., Hingorani L., Derendorf H. Absorption, metabolism, and antioxidant effects of pomegranate (Punica granatum l.) polyphenols after ingestion of a standardized extract in healthy human volunteers. J. Agric. Food Chem. 2006, 54:8956-8961.
30. Mertens-Talcott S.U., Lee J.H., Percival S.S., Talcott S.T. Induction of cell death in Caco-2 human colon carcinoma cells by ellagic acid rich fractions from muscadine grapes (Vitis rotundifolia). J. Agric. Food Chem. 2006, 54:5336-5343.
31. Nandi S., Vracko M., Bagchi M.C. Anticancer activity of selected phenolic compounds: QSAR studies using ridge regression and neural networks. Chem. Biol. Drug Des. 2007, 70:424-436.
32. Narayanan B.A., Geoffroy O., Willingham M.C., Re G.G., Nixon D.W. P53/p21(WAF1/CIP1) expression and its possible role in G1 arrest and apoptosis in ellagic acid treated cancer cells. Cancer Lett. 1999, 136:215-221.
33. Ohkawa H., Ohishi N., Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 1979, 95:351-358.
34. Patel T., Gores G.J. Apoptosis and hepatobiliary disease. Hepatology 1995, 21:1725-1741.
35. Possati L., Rocchetti R., Talevi S., Beatrici V., Margiotta C., Ferrante L., Calza R., Sagrini D., Ferri A. The role of peroxisome proliferator-activated receptor gamma in bladder cancer in relation to angiogenesis and progression. Gen. Pharmacol. 2000, 35:269-275.
36. Rajesh D., Schell K., Verma A.K. Ras mutation, irrespective of cell type and p53 status, determines a cell's destiny to undergo apoptosis by okadaic acid, an inhibitor of protein phosphatase 1 and 2A. Mol. Pharmacol. 1999, 56:515-525.
37. Rice-Evans C., Miller N., Paganga G. Antioxidant properties of phenolic compounds. Trends Plant Sci. 1997, 2:152-159.
38. Roux P.P., Blenis J. ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions. Microbiol. Mol. Biol. Rev. 2004, 68:320-344.
39. Roychowdhury A., Dey R.K., Bandyapadhyay A., Bhattacharya P., Mitra R.B., Dutta R. Study of mutated p53 protein by immunohistochemistry in urothelial neoplasm of urinary bladder. J. Indian Med. Assoc. 2012, 110:393-396.
40. Schwab M., Reynders V., Ulrich S., Zahn N., Stein J., Schroder O. PPARgamma is a key target of butyrate-induced caspase-3 activation in the colorectal cancer cell line Caco-2. Apoptosis 2006, 11:1801-1811.
41. Seeram N.P., Aronson W.J., Zhang Y., Henning S.M., Moro A., Lee R.P., Sartippour M., Harris D.M., Rettig M., Suchard M.A., Pantuck A.J., Belldegrun A., Heber D. Pomegranate ellagitannin-derived metabolites inhibit prostate cancer growth and localize to the mouse prostate gland. J. Agric. Food Chem. 2007, 55:7732-7737.
42. Selma M.V., Espin J.C., Tomas-Barberan F.A. Interaction between phenolics and gut microbiota: role in human health. J. Agric. Food Chem. 2009, 57:6485-6501.
43. Su F., Li H., Yan C., Jia B., Zhang Y., Chen X. Depleting MEKK1 expression inhibits the ability of invasion and migration of human pancreatic cancer cells. J. Cancer Res. Clin. Oncol. 2009, 135:1655-1663.
44. Teng C.H., Huang W.N., Meng T.C. Several dual specificity phosphatases coordinate to control the magnitude and duration of JNK activation in signaling response to oxidative stress. J. Biol. Chem. 2007, 282:28395-28407.
45. Urech K., Buessing A., Thalmann G., Schaefermeyer H., Heusser P. Antiproliferative effects of mistletoe (Viscum album L.) extract in urinary bladder carcinoma cell lines. Anticancer Res. 2006, 26:3049-3055.
46. Vicente-Sanchez C., Egido J., Sanchez-Gonzalez P.D., Perez-Barriocanal F., Lopez-Novoa J.M., Morales A.I. Effect of the flavonoid quercetin on cadmium-induced hepatotoxicity. Food Chem. Toxicol. 2008, 46:2279-2287.
47. Wang J., Friedman E. Downregulation of p53 by sustained JNK activation during apoptosis. Mol. Carcinog. 2000, 29:179-188.
48. Wu J., Guan M., Wong P.F., Yu H., Dong J., Xu J. Icariside II potentiates paclitaxel-induced apoptosis in human melanoma A375 cells by inhibiting TLR4 signaling pathway. Food Chem. Toxicol. 2012, 50:3019-3024.
49. Yeh C.C., Kuo H.M., Li T.M., Lin J.P., Yu F.S., Lu H.F., Chung J.G., Yang J.S. Shikonin-induced apoptosis involves caspase-3 activity in a human bladder cancer cell line (T24). In Vivo 2007, 21:1011-1019.
50. Yokozawa T., Kim Y.A., Kim H.Y., Okamoto T., Sei Y. Protective effect of the Chinese prescription Kangen-karyu against high glucose-induced oxidative stress in LLC-PK1 cells. J. Ethnopharmacol. 2007, 109:113-120.
51. Yujiri T., Sather S., Fanger G.R., Johnson G.L. Role of MEKK1 in cell survival and activation of JNK and ERK pathways defined by targeted gene disruption. Science 1998, 282:1911-1914.